Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD

Eye

Volumn 25, Issue 9, 2011, Pages 1181-1186

  Gutfleisch, M ^a   Heimes, B ^a   Schumacher, M ^a   Dietzel, M ^a   Lommatzsch, A ^a   Bird, A ^b   Pauleikhoff, D ^a  

^a ST FRANZISKUS HOSPITAL   (Germany)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

age related macular degeneration; bevacizumab (Avastin); pegaptanib (Macugen); ranibizumab (Lucentis); retinal pigment epithelium detachment; retinal pigment epithelium tears

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DETERIORATION; DISEASE SEVERITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MORPHOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PROGNOSIS; RETINA DETACHMENT; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETROSPECTIVE STUDY; SCAR FORMATION; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY;

EID: 80052613712     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.146     Document Type: Article

References (32)

1. Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, Schmidt-Erfurth U. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol 2006; 141(2): 396-398.
2. Muller C, Spital G, Radermacher M, Dohrmann J, Lommatzsch A, Pauleikhoff D. Pigment epithelium detachments in AMD (age-associated macular degeneration) and 'polypoid choroidal vasculopathy'. A fluorescein and indocyanine green angiography study. Ophthalmologe 2002; 99(2): 85-89. (Pubitemid 36362200)
3. Panagiotidis D, Karagiannis DA, Baltatzis S. Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 2006; 16(2): 326-329. (Pubitemid 43874406)
4. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981; 65(6): 417-422. (Pubitemid 11046373)
5. Pauleikhoff D, Loffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240(7): 533-538. (Pubitemid 36097080)
6. Gass JD. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 1984; 98(6): 700-706. (Pubitemid 15219227)
7. Yeo JH, Marcus S, Murphy RP. Retinal pigment epithelial tears. Patterns and prognosis. Ophthalmology 1988; 95(1): 8-13. (Pubitemid 18052396)
8. Thompson JT. Retinal pigment epithelial tear after transpupillary thermotherapy for choroidal neovascularization. Am J Ophthalmol 2001; 131(5): 662-664. (Pubitemid 32422131)
9. Arnold JJ, Blinder KJ, Bressler NM, Bressler SB, Burdan A, Haynes L et al. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: Case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol 2004; 137(4): 683-696.
10. Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y et al. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol 2004; 122(4): 453-459. (Pubitemid 38456279)
11. Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001; 131(4): 518-520. (Pubitemid 32273446)
12. Goldstein M, Heilweil G, Barak A, Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 2005; 19(12): 1315-1324. (Pubitemid 43148509)
13. Pece A, Introini U, Bottoni F, Brancato R. Acute retinal pigment epithelial tear after photodynamic therapy. Retina 2001; 21(6): 661-665. (Pubitemid 34027784)
14. Schoeppner G, Chuang EL, Bird AC. The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. Am J Ophthalmol 1989; 108(6): 683-685. (Pubitemid 20013090)
15. Carvounis PE, Kopel AC, Benz MS. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 2007; 143(3): 504-505.
16. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006; 141(4): 752-754.
17. Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD. Graefes Arch Clin Exp Ophthalmol 2007; 245(7): 1037-1040.
18. Lee GK, Lai TY, Chan WM, Lam DS. Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245(8): 1225-1227. (Pubitemid 47034347)
19. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006; 142(6): 1068-1070. (Pubitemid 44853878)
20. Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007; 27(5): 541-551. (Pubitemid 46905143)
21. Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe 2008; 105(2): 158-164.
22. Smith BT, Kraus CL, Apte RS. Retinal pigment epithelial tears in ranibizumab-treated eyes. Retina 2009; 29(3): 335-339.
23. Group MPS. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991; 109(9): 1242-1257.
24. Participants VR. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: Update. Retina 2005; 25(2): 119-134.
25. Jaissle GB, Szurman P, Bartz-Schmidt KU. Recommendation for the implementation of intravitreal injectionsFstatement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monbl Augenheilkd 2005; 222(5): 390-395. (Pubitemid 40825853)
26. Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Zeimer M, Pauleikhoff D. Serous pigment epithelial detachment in age-related macular degeneration: Comparison of different treatments. Eye (Lond) 2009; 23(12): 2163-2168.
27. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008; 28(9): 1265-1269.
28. Wong LJ, Desai RU, Jain A, Feliciano D, Moshfeghi DM, Sanislo SR et al. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Retina 2008; 28(8): 1151-1158.
29. Kiss C, Michels S, Prager F, GeitzenauerW, Schmidt-Erfurth U. Retinal pigment epithelium tears following intravitreal ranibizumab therapy. Acta Ophthalmol Scand 2007; 85(8): 902-903. (Pubitemid 350142817)
30. Sarraf D, Reddy S, Chiang A, Yu F, Jain A. A new grading system for retinal pigment epithelial tears. Retina 2010; 30(7): 1039-1045.
31. Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y et al. Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol Scand 2008; 86(4): 372-376.
32. Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium. Eye 1988; 2(Part 1): 106-113. (Pubitemid 18086048)